Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 138

Daily deal net: February 18, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Feb 18, 2020

OMass compiles $53.9m series A

University of Oxford-founded OMass Therapeutics has extended its series A round to progress a pipeline targeting immunological and genetic disorders.

Feb 18, 2020

Amber rams through $28m series A

Paradigm co-led the latest round for crypto trading services provider Amber, with Coinbase and Blockchain.com also investing.

Feb 18, 2020

CloudCath cleans up with series A funding

Stanford-StartX Fund contributed to a $12m round for catheter monitor developer CloudCath, whose clinical advisory chairman hails from Stanford University.

Feb 17, 2020

Corporate venturing deal net: 10-14 February 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds

Feb 14, 2020

Grabwheels rolls on with $30m from Kymco

Grab's electric scooter rental service has picked up a series A investment from motorcycle producer and new strategic partner Kymco.

Feb 14, 2020

Oxford VR boxes in $13m series A

VR mental health software developer Oxford VR secured the return of both OUI and OSI to increase its funding to more than $17m.

Feb 13, 2020

Daily deal net: February 12, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Feb 12, 2020

Baseconnect links to corporates in series A round

Yahoo Japan, Uzabase, Orico and Nihon Unisys all chipped into a $16.4m round for the corporate information database operator, which will spend the cash on technology development and marketing.

Feb 10, 2020

Sonoma sends for Lyell in $40m series A

Sonoma Biotherapeutics has emerged from stealth with $40m to develop regulatory T-cell therapies for autoimmune and degenerative diseases.

Feb 10, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here